Treatment of dystonia occurring in parkinsonian syndromes by botulinum toxin

European Neurology

Volumn 37, Issue 1, 1997, Pages 66-67

  Limousin, Patricia ^a   Memin, Bernard ^a   Pollak, Pierre ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIPLOPIA; DYSPHAGIA; DYSTONIA; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PARKINSONISM; PRIORITY JOURNAL; PTOSIS; RETROSPECTIVE STUDY;

AGED; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PARKINSON DISEASE, SECONDARY; TREATMENT OUTCOME;

EID: 0031032939     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117409     Document Type: Article

References (6)

1. Poewe WH, Lees AJ, Stern GM: Dystonia in Parkinson's disease: Clinical and pharmacological features. Ann Neurol 1988;23:73-78.
2. Lees AJ, Stem GM: Bromocriptine in treatment of levodopa-induccd cnd-of-dose dystonia. Lancet 1980;ii:215-216.
3. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin. N Engl J Med 1991:324:1186-1194.
4. Giladi N, Meer J, Honigman S:The use of botulinum toxin to treat‘striatal’ toes. J Neurol Ncurosurg Psychiatry 1994:57:659.
5. Pacchetti C, Albani G, Martignoni E, Godi L, Alfonsi E, Nappi G: OfT painful dystonia in Parkinson's disease treated with botulinum toxin. Mov Disord 1995;10:333-336.
6. Scott AB, Kennedy RA, Stubbs HA: Botulinum toxin injection as a treatment for blepharospasm. Arch Ophthalmol 1985; 103:347-350.